drugset / Trial / NCT00803673

A Healthy Volunteer Study With Inhaled GSK573719 and Placebo

NCT00803673

Phase 1 Completed 36 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

This study is to look at a new formulation of GSK573719 to see if it is safe and tolerated in healthy volunteers

Timeline

Start
2008-05-05
Primary completion
2008-10-16
Completion
2008-10-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Umeclidinium Other / unclassified 100 ug Inhaled
Subject Umeclidinium Other / unclassified 500 ug Inhaled
Subject Umeclidinium Other / unclassified 1000 ug Inhaled